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Editorial: Bioethics and Ideas 
 
   There are seven papers in this issue from authors 
around the world. First is my report of the AUSN 
Conference on Bioethics, Public Health and Peace for 
Indigenous Peoples, which was held in Mexico City as 
a Satellite event of the 12th World Congress of 
Bioethics, which I also attended, spoke at and chaired 
several several sessions at.  The theme of bioethics for 
indigenous peoples is stimulating and there is a variety 
of views that affect both medical ethics and 
environmental ethics. Since the American University of 
Sovereign Nations (AUSN) launched our MPH and 
Masters in Bioethics and Global Public Health 
(MBGPH) degrees we have also started to see a 
number of students from around the world start the first 
MBGPH in the world. The curriculum is on the last 
pages of this issue. There are many students and a lot 
of discussion between people across the world.   
   The paper by the Boyd’s is stimulated by the 
discussions at ABC14 in India in 2013, and explores 
lessons which shape the future of who we want to 
become. Dr. Simonstein explores the ethics of autism 
and how our ideas of what it means to be a human in 
the current society shape diagnoses of health and 
wholeness.  The broad meaning of health includes 
physical, mental and spiritual elements. The papers of 
Rafique and Muktamiroh examine definitions of what is 
ethical and unethical, against a milieu of what current 
“Bioethics” judges to be ethical and what is not.  
Aggarwal discusses abuses of ethics across borders, 
when the perpetrators knew what they were doing. 
  The final paper by Lajaunie et al. reports on meetings 
in Asia to discuss the ethics of cataloging infectious 
diseases and the agents that cause it.  We will expect 
to see greater attention on ethics of public health with 
the emergence of Ebola as a disease affecting 
thousands not just tens or hundreds as in the past 
known epidemics.  We hope more readers will submit 
papers for publication.  
  - Darryl Macer 
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Abstract 
A first workshop held within the framework of the 
PathodivSEA project has been the occasion to identify 
the major research challenges regarding the 
emergence of zoonotic infectious diseases in South 
East Asia and the spread of pathogens responsible 
from those diseases. Based on supporting evidences 
indicating the zoonotic origins of those diseases, it 
appeared urgent to investigate the factors controlling 
the pathogens-human interface by addressing the “One 
Health” concept which integrates the study of human 
and animal health with conservation medicine. The 
necessity of pathogen, vector and reservoir 
identification (barcoding), pathogens and other tissues’ 
preservation (biobanking) and open databases creation 
(ebanking) has been recognized, along with the 
importance of ethical and legal considerations.  
 
Introduction 
The project PathodivSEA (“Pathogen diversity in 
Southeast Asia”, AFD-CNRS) aims to develop a 
research network in South East-Asia to measure the 
diversity of zoonotic agents (virus, bacteria, parasites) 
and their vectors and reservoirs, allowing sharing tools 
and concepts in relation to their identification 
(barcoding), the preservation of tissues and living 
organisms (biobanking) and open databases 
(ebanking) in order to better understand their ecology 
(transmission) and evolutionary dynamics facing the 
ongoing environmental changes that affect South-East 
Asia1-2. Southeast Asia is a hotspot for emerging 
infectious diseases3, and the major explanatory factor 
of the increase of outbreaks of those diseases is 
thought to be biodiversity loss4. 
The first workshop held within the framework of the 
PathodivSEA project has been the occasion to identify 
the major research challenges regarding the 
emergence of zoonotic infectious diseases in South-
East Asia and the spread of pathogens responsible of 
those diseases. This paper aims to present a short 
synthesis of the main observations done during the 
workshop through the various presentations in different 
disciplines, results to be taken into account in order to 
tackle the pressing research issues identified. 
The first findings can be summarized by a variation 
at different scales (global, regional, local) following a 
geographical axis from West to East (Europe to Asia) 
and a decreasing gradient of integration of results from 
human health to medicine conservation. We will 
discuss those differences through examples concerning 
barcoding and biobanking as well as microbiology and 
parasitology. 
The questions raised in the areas of ethics or law 
and policy by those scientific studies are important to 
highlight as in one hand researchers might not be 
aware of the need to incorporate some ethical or legal 
rules into their studies and in the other hand their 
findings could benefit the whole community if they were 
taken into consideration by policy-makers to design an 
appropriate decision framework. 
 
Material and Methods 
During the workshop held in Singapore in August 
2013, oral presentations from regional participants 
(Cambodia, Indonesia, Lao PDR, Malaysia, Singapore 
and Thailand) dealt with several topics related to 
epidemiology of infectious diseases and emerging 
diseases, wildlife conservation and diseases 
(conservation medicine), pathogens, vectors and 
reservoirs identification (screening and barcoding), 
tissues (wildlife) and pathogen preservation 
(biobanking), database (ebanking), ethics and 
regulations. 
Based on these presentations, we proposed a 
schema of the advances of barcoding / biobanking / 
ebanking / ethics and law in relation to the different 
fields that are to some degree concerned with infectious 
diseases: public health (medicine), animal health 




Table 1 summarizes the advancements of each 
following subjects: barcoding, biobanking, ebanking, 
ethics and law in relation to public and animal 
(domestic and wildlife health).  
 
Discussion 
Barcoding in medicine, veterinary medicine and 
conservation biology 
Efforts to control infectious diseases depend upon 
our ability to identify pathogens, parasites, vectors and 
reservoirs. In medicine, there is a perpetual quest for a 
gold standard test, which refers to a diagnostic test or 
benchmark that is the best available under reasonable 
conditions5. In the field of veterinary medicine, 
development and validation of diagnostic tools are 
under the head of the OIE (World Organization for 
Animal Health), which recognizes and gives label to 
national reference centers (usually specialized in one or 
several infectious diseases). As a matter of fact, this 
procedure is modeled on the process used by the WHO 
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Table 1. Comparisons of the advancements of each following subjects barcoding, biobanking, ebanking, ethics and law 
and regulation in relation to public health, animal health and wildlife conservation. 
 





Screening/barcoding Gold standard test, reference 
laboratory WHO 
OIE, reference laboratory OIE Barcoding (BoL, 
Barcoding of Life) 
Biobanking Reference centers (international, 
national) 
Institution initiatives Natural History 
Museum, Institution 
initiatives 
Ebanking Reference centers OIE, FAO GBIF, BOLD, … 
Ethics WHO/CIOMS International Ethical 
Guidelines for Biomedical 
Research Involving Human 
Subjects 
OIE Collaborating Centre for 




International law and 
regulation  
WHO International Health 
Regulations  
OIE, WHO (zoonoses) CDB, CITES*, CMS**  
*CITES: Convention on International Trade in Endangered Species of Wild Fauna and Flora  
**CMS: Convention on the Conservation of Migratory Species of Wild Animals 
 
In the field of biodiversity, less than 10% of the all 
species have been described. As few taxonomists can 
identify species on a morphologically-basis, it has been 
proposed to develop an international consortium, the 
Barcoding of Life (BOL), which aims at promoting and 
developing molecular identification of living organisms6. 
DNA barcoding systems employ a short, standardized 
gene region to identify species (usually the 
mitochondrial COI gen). Hence, it appears that 
screening and identification although using similar 
genetic methodologies, may not use similar words 
(barcoding is rarely used in veterinary medicine, or in 
parasitology). Moreover, they rely on different protocols, 
and distinct data base systems (see below). 
 
Biobanking  
This discrepancy in screening and identification in 
pathogens, parasites, vectors, reservoirs can be also 
observed in the way practitioners from the different 
fields preserve tissues, parasites and pathogens. 
Human medicine early recognized the necessity to 
cryopreserve human tissues and pathogens. 
Preservation of materials allows improvement of 
screening, genetic studies and treatments. 
Storage of voucher specimens from wildlife are 
usually realized in internationally recognized institutions 
like national natural history museums6. This also 
concerns parasites but more rarely microbes, which 
might be conserved in medical institutions when they 
are of zoonotic concerns. 
Finally, parasites and pathogens of domestic 
animals seem not to be preserved in official and 
recognized institutions, apart from OIE collaborative 
centers (although their primary missions are diagnostic 
and control). 
 
Ebanking and open databases 
Several international and national databases are 
available (WHO, OIE, FAO, Gideon data base, etc) with 
some geo-referencing. Most of them concern reports of 
disease outbreaks and few give access to information 
on tissues/pathogens/parasites preserved in specific 
institutions. This is once more particularly true for 
veterinary medicine and conservation medicine. 
In the field of biodiversity, an informatics workbench, 
The Barcode of Life Data System (BOLD) has been 
developed to aid in the acquisition, storage, analysis 
and publication of DNA barcode records7. The project 
CERoPath (“Community Ecology of Rodents and their 
Pathogens in Southeast Asia”, (www.ceropath.org) for 
reservoirs of rodent-borne diseases in South-East Asia 
is one example. By assembling molecular, 
morphological and distributional data, it bridges a 
traditional bioinformatics chasm8.  
 
Pathogens research confronted with Ethics and Law  
The ethical issues linked to research in infectious 
diseases are diverse and depend notably on: the 
source of material studied (animal, human), the storage 
of sample for future uses such as in the case of 
predictive medicine, or the activity of research itself.  
The constitution of biobanks implies the notion of 
consent of the persons concerned. As stated in the 
Universal Declaration on Bioethics and Human Rights 
(2005) “scientific research should only be carried out 
with the prior, free, express and informed consent of 
the person concerned”. The need of prior informed 
consent for a future storage and use of any removed 
part of a human body challenged the idea of the 
absence of proprietary rights over our body or body 
parts9. The notion of consent is assumed in Material 
Transfer Agreements (MTAs) signed in the case of 
transfer of research material in order to precise the use 
of the material and to define the rights over material 
and any derivatives. The example of the UK biobank, a 
long-term research resource, shows that the consent 
encompasses many aspects including the use of 
sensitive information, a possible link to the medical 
record, the confidentiality with anonymisation but giving 
a possibility to re-contact the participant in the future. It 
illustrates the necessity to clearly inform the 
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participants about the actual or potential uses of 
samples and to give him the right to withdraw.  
Regarding animal health, ethics concerns should 
comprehend animal welfare and take into consideration 
animal suffering by enacting good laboratory practices 
and ultimately addressing the legal issues of animal 
rights. 
In addition, the activity of research should respond 
to the ethical concerns of solidarity and mutual 
assistance10 and include the necessity for researchers 
to return benefits to providers. 
Some ethical issues such as the prior informed 
consent or mutual agreement are integrated into the 
Convention on Biodiversity (CBD, 1992) in the article 
providing the access to genetic resources. The 
Convention also regulates the issue of benefit sharing 
and solidarity with a particular concern for the respect 
of traditional knowledge. In order to implement those 
provisions of the Convention, the Nagoya Protocol 
(2010) detailed the access obligations to be 
implemented at the national level insisting on the need 
to promote and encourage research contributing to 
biodiversity conservation and sustainable use. 
Concerning the benefit sharing obligations, the non-
monetary part relates to the sharing of research results, 
transfer of technology or training and education. 
ASEAN urges the States to adopt national measures 
regarding the access to genetic resources and benefit 
sharing and to ensure its enforcement through 
institutionalized arrangements.  
The monetary benefits should be shared with the 
provider and there should be a necessary trade-off 
between the legal protection of Intellectual Property 
Rights and the respect of benefit sharing, traditional 
knowledge and cultural biodiversity. 
The “One Health” approach could help to turn those 
ethical and legal considerations into practical policies 
integrating the notions of equity and justice. 
 
Conclusion 
Based on supporting evidences indicating the 
zoonotic origins of those diseases, it appeared urgent 
to investigate the factors controlling the pathogens-
human interface by addressing the “One Health” 
concept which integrates the study of human and 
animal health with conservation medicine as well as 
other disciplines that might influence those factors such 
as policy, law or ethics.  
Moreover, important achievements should be 
accomplished in terms of barcoding (sharing protocols 
and concepts), biobanking (particularly for 
parasites/pathogens of animals and wildlife) and 
ebanking (access and sharing of geo-referenced data, 
collections and tissues). 
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According to many the most promising frontier in 
modern medicine is genetic research. Genetic science 
finds its modern origin in Gregor Mendel, who in 1866 
discovered the laws of heredity. The heart of this hard 
science comes from the secret of the nucleus. The 
nucleus of an organism possesses the chromosomes, 
which has the DNA (deoxyribonucleic acid) that serves 
as the very building blocks of life. The study of the DNA 
has propelled the advances made in genetic research. 
These advances have opened doors to many 
possibilities in medicine and patient care. But there are 
moral issues to consider.  
 
Ethics and Genetics 
According to John Harris, “ethical issues are raised 
by the use of embryonic cells, tissues, or other products 
and indeed the use of neonates and aborted fetuses as 
sources of therapeutic or experimental material”. 13 
Scientists say that genetic research is vital. Today, it is 
modern medicine’s most promising weapon in the battle 
against certain types of cancer, Parkinson’s disease, 
Alzheimer’s disease, diabetes and other degenerative 
genetic malignancies.  
                                                
13  John Harris, Clones, Genes and Immortality (Oxford: 
Oxford University Press), 43. 
